Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

'More upgrades will hike the Gorshkov's price'
A consummate Russian diplomat, Vyacheslav Trubnikov is returning home this week after having served as serving as Russia’s ambassador to India for nearly five years. The period has seen several highs and lows in the bilateral relationship, including the building of the first civil nuclear power plants by Russia and nagging problems over defence spares and equipment. Edited excerpts from an interview with Jyoti Malhotra

VE Commercial Vehicles' October sales up 65%
Auto maker VE Commercial Vehicles today reported 65.11 per cent growth in its total sales of Eicher trucks and buses in October at 2,257 units.

News of the day

No data on Muslim employees in Central govt jobs: Khurshid
The government today said it does not maintain statistics of Muslim employees in Central government services but it has data for the five minority communities as a whole.
Online Business

SC refuses relief to Roche on patent plea against Cipla

The Supreme Court today refused to give any relief to Swiss pharma firm Hoffman La Roche Ltd that had challenged a Delhi High Court order allowing Cipla to manufacture and sell a generic version of lung cancer drug "Erlotinib". - SC to commence final hearing on Ambani gas row on Oct 20 - Govt for filling up vacancies of judges in SC, HC - SC upholds law on office of profit - SC restores powers to Prasar Bharati CEO - SC pulls up Ranbaxy for delayed raising of refund issue - SC pulls up Ranbaxy for delayed raising of refund issue A bench headed by Justice Dalveer Bhandari, while disposing of Roche"s plea, said that it was not inclined to give any relief and asked the single judge of the High Court, before whom the original petition is pending, to decide the matter expeditiously. Besides, it said that the single judge should not be influenced by any observations made by the division bench. The division bench of the High Court besides imposing a cost of Rs five lakh on the Swiss Company had also dismissed its plea seeking to restrain Cipla from manufacturing and selling the generic drug till the issue of patent rights was decided through litigation.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009